About: Methoxphenidine

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Methoxphenidine (methoxydiphenidine, 2-MeO-Diphenidine, MXP) is a dissociative of the diarylethylamine class that has been sold online as a designer drug. Methoxphenidine was first reported in a 1989 patent where it was tested as a treatment for neurotoxic injury. Shortly after the 2013 UK ban on arylcyclohexylamines methoxphenidine and the related compound diphenidine became available on the gray market, where it has been encountered as a powder and in tablet form. Though diphenidine possesses higher affinity for the NMDA receptor, anecdotal reports suggest methoxphenidine has greater oral potency. Of the three isomeric anisyl-substituents methoxphenidine has affinity for the NMDA receptor that is higher than 4-MeO-Diphenidine but lower than 3-MeO-Diphenidine, a structure–activity relatio

Property	Value
dbo:abstract	Methoxphenidine (methoxydiphenidine, 2-MeO-Diphenidine, MXP) is a dissociative of the diarylethylamine class that has been sold online as a designer drug. Methoxphenidine was first reported in a 1989 patent where it was tested as a treatment for neurotoxic injury. Shortly after the 2013 UK ban on arylcyclohexylamines methoxphenidine and the related compound diphenidine became available on the gray market, where it has been encountered as a powder and in tablet form. Though diphenidine possesses higher affinity for the NMDA receptor, anecdotal reports suggest methoxphenidine has greater oral potency. Of the three isomeric anisyl-substituents methoxphenidine has affinity for the NMDA receptor that is higher than 4-MeO-Diphenidine but lower than 3-MeO-Diphenidine, a structure–activity relationship shared by the arylcyclohexylamines. (en)
dbo:casNumber	127529-46-8
dbo:fdaUniiCode	H2W7A6GZGX
dbo:pubchem	67833251
dbo:thumbnail	wiki-commons:Special:FilePath/Methoxphenidine_structure.svg?width=300
dbo:wikiPageID	41255861 (xsd:integer)
dbo:wikiPageLength	10107 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1099858799 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Designer_drug dbc:Designer_drugs dbc:NMDA_receptor_antagonists dbc:Phenol_ethers dbc:Piperidines dbr:Ephenidine dbr:Anisole dbr:Lefetamine dbr:Lorazepam dbr:MT-45 dbr:Driving_under_the_influence dbr:AD-1211 dbr:Fluorolintane dbc:Diarylethylamines dbc:Dissociative_drugs dbr:Health_Canada dbr:Lanicemine dbr:Diphenidine dbr:Dissociative_drug dbr:Arylcyclohexylamine dbr:Phencyclidine dbr:Structure–activity_relationship dbr:NMDA_receptor_antagonist dbr:NMDA_receptor
dbp:c	20 (xsd:integer)
dbp:casNumber	127529 (xsd:integer)
dbp:chemspiderid	52085156 (xsd:integer)
dbp:h	25 (xsd:integer)
dbp:iupacName	-1 (xsd:integer)
dbp:legalCa	Schedule I (en)
dbp:legalDe	NpSG (en)
dbp:legalStatus	Illegal in China and Sweden (en)
dbp:legalUk	PSA (en)
dbp:n	1 (xsd:integer)
dbp:o	1 (xsd:integer)
dbp:pubchem	67833251 (xsd:integer)
dbp:routesOfAdministration	Oral, Rectal (en)
dbp:smiles	COC1=CCN3CCCCC3 (en)
dbp:stdinchi	1 (xsd:integer)
dbp:stdinchikey	QXXCUXIRBHSITD-UHFFFAOYSA-N (en)
dbp:unii	H2W7A6GZGX (en)
dbp:wikiPageUsesTemplate	dbt:Drugbox dbt:Hallucinogens dbt:Ionotropic_glutamate_receptor_modulators dbt:Reflist dbt:Short_description dbt:Cascite
dcterms:subject	dbc:Designer_drugs dbc:NMDA_receptor_antagonists dbc:Phenol_ethers dbc:Piperidines dbc:Diarylethylamines dbc:Dissociative_drugs
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatNMDAReceptorAntagonists yago:Adversary109773245 yago:CausalAgent100007347 yago:LivingThing100004258 yago:Object100002684 yago:Organism100004475 yago:Person100007846 yago:PhysicalEntity100001930 yago:YagoLegalActor yago:YagoLegalActorGeo dbo:Drug yago:Whole100003553
rdfs:comment	Methoxphenidine (methoxydiphenidine, 2-MeO-Diphenidine, MXP) is a dissociative of the diarylethylamine class that has been sold online as a designer drug. Methoxphenidine was first reported in a 1989 patent where it was tested as a treatment for neurotoxic injury. Shortly after the 2013 UK ban on arylcyclohexylamines methoxphenidine and the related compound diphenidine became available on the gray market, where it has been encountered as a powder and in tablet form. Though diphenidine possesses higher affinity for the NMDA receptor, anecdotal reports suggest methoxphenidine has greater oral potency. Of the three isomeric anisyl-substituents methoxphenidine has affinity for the NMDA receptor that is higher than 4-MeO-Diphenidine but lower than 3-MeO-Diphenidine, a structure–activity relatio (en)
rdfs:label	Methoxphenidine (en)
owl:sameAs	freebase:Methoxphenidine yago-res:Methoxphenidine wikidata:Methoxphenidine dbpedia-hr:Methoxphenidine https://global.dbpedia.org/id/Yio6
prov:wasDerivedFrom	wikipedia-en:Methoxphenidine?oldid=1099858799&ns=0
foaf:depiction	wiki-commons:Special:FilePath/Methoxphenidine_structure.svg
foaf:isPrimaryTopicOf	wikipedia-en:Methoxphenidine
is dbo:wikiPageDisambiguates of	dbr:MXP
is dbo:wikiPageRedirects of	dbr:Methoxydiphenidine dbr:Methoxyphenidine dbr:2-MeO-Diphenidine dbr:1-(1-(2-methoxyphenyl)-2-phenylethyl)piperidine
is dbo:wikiPageWikiLink of	dbr:List_of_designer_drugs dbr:Delucemine dbr:Remacemide dbr:UWA-001 dbr:Ephenidine dbr:N-Methyl-D-aspartic_acid dbr:NPDPA dbr:Controlled_Drugs_and_Substances_Act dbr:Lefetamine dbr:MT-45 dbr:Budipine dbr:AD-1211 dbr:Fluorolintane dbr:Lanicemine dbr:Diphenidine dbr:C20H25NO dbr:Methoxydiphenidine dbr:Methoxyphenidine dbr:Indapyrophenidone dbr:MXP dbr:2-MeO-Diphenidine dbr:1-(1-(2-methoxyphenyl)-2-phenylethyl)piperidine
is foaf:primaryTopic of	wikipedia-en:Methoxphenidine

This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License